What federal and state drug rules mean
What MOTS-c legal status means at a pharmacy
The FDA hadn't approved MOTS-c as a drug in 2026. A meeting was set for July 23-24, 2026, but a meeting isn't a ruling.
What federal drug status means for you now
A pharmacy counter makes the question practical. MOTS-c isn't approved by the FDA for any illness.
Sellers call MOTS-c lab material, not medicine for people. An FDA panel put the substance on a 2026 meeting list.
The meeting was set for July 23-24, 2026. The panel planned to discuss whether pharmacies could use the raw ingredient.
That federal list covers ingredients for medicine made for one patient. A meeting doesn't add MOTS-c to the final list.
The meeting also didn't create a prescription drug. These are broad facts, not medical or legal advice for you.
What drug approval MOTS-c doesn't have
Cells use DNA instructions to make MOTS-c, a short protein. That natural source doesn't make MOTS-c an approved medicine.
MOTS-c is not an FDA-approved drug for any use. A pharmacy can't start with any raw ingredient it wants.
For one patient's medicine, federal law limits the raw ingredients. An ingredient may qualify because an approved drug already uses it.
An official drug reference may also allow an ingredient. The FDA's final list of raw ingredients offers another route.
For other ingredients, the FDA asks pharmacy advisers to review the facts. Their advice is one step, not a ruling.
MOTS-c was set for that kind of review. A planned review doesn't put the protein on the final list.
That difference reaches the pharmacy counter. Review alone doesn't create medicine your doctor can prescribe.
How federal rules cover pharmacy-made drugs
Federal law has one set of rules for medicine made for a named patient. Another set covers registered plants that make larger batches.
The FDA keeps a closer watch on those larger plants. Both kinds of places must start with an allowed raw ingredient.
An ingredient may appear in an official drug reference. An approved medicine or an FDA list may also allow it.
Other ingredients go through a public FDA review. A talk by pharmacy advisers is only one step.
Approval of the finished drug is a separate question. MOTS-c doesn't have approval as a finished drug.
Read how pharmacy-made drugs are reviewed for this issue. MOTS-c was still waiting for a decision.
This page claims no numbered legal category for MOTS-c. A category used for another protein gives MOTS-c no permission.
“Under review” means the work isn't finished. The phrase doesn't mean approved.
What the 2026 meeting couldn't settle by itself
The FDA meeting list named MOTS-c itself. The meeting was set for July 23-24, 2026.
The panel planned to weigh MOTS-c for the raw-ingredient list. The agenda named two forms of MOTS-c without explaining them here.
The agenda also listed BPC-157 and TB-500, two other lab substances. It listed KPV too, but none was placed on the final list.
After the talk, the panel could advise the FDA. The panel couldn't issue drug approval by itself.
The sources confirmed no broader 2026 rule for small proteins. Claims of a wider change remained unproved.
Some reports call the meeting a green light. That phrase goes well past the agenda.
What happens before a pharmacy can make medicine
A licensed prescriber first checks one person's needs. If the medicine fits, the prescriber writes a prescription in that person's name.
A state-licensed pharmacy may then make that medicine. A registered drug plant may make larger batches.
A video visit may be part of the health check. The same rules for raw ingredients still apply.
Federal rules control which raw ingredients may be used. A known safety problem can still block pharmacy use.
These are broad legal facts, not care advice. No seller, clinic, or pharmacy is named here.
What does legal mean for MOTS-c?
The FDA hasn't approved MOTS-c as a drug for people. An FDA agenda named it for July 23-24, 2026.
The panel was considering a place on the raw-ingredient list. That meeting alone didn't change the law.
State buying rules may differ. A pharmacist or local lawyer can explain the rule in your state.
What rules cover buying MOTS-c?
The FDA hasn't approved MOTS-c for human use. Sellers label the substance as a chemical for lab research.
The main sport groups also bar MOTS-c. State buying rules may differ from one place to another.
What does store medicine approval require?
MOTS-c lacks approval as a drug or store medicine. No use, product form, or amount has approval.
When may a pharmacy make MOTS-c?
A pharmacy may use only a raw ingredient allowed by federal law. MOTS-c isn't on the final list of allowed bulk ingredients.
The agenda set a review for July 23-24, 2026. That review wasn't routine permission to make the drug.
Pharmacy-made medicine also needs a licensed prescriber's review. The named patient still needs a prescription.
What did the federal pharmacy review mean?
The FDA hasn't approved MOTS-c as a drug. A pharmacy panel planned to review it at the July 23-24, 2026 meeting.
The panel was weighing the raw ingredient for its federal list. No final place on that list is claimed here.
What MOTS-c can do to an athlete's standing
The leading sport rulebooks bar MOTS-c all year. They treat it as a short protein that may change how the body uses fuel.
An athlete could face a penalty after using MOTS-c. The sport ban is separate from drug approval and state buying law.